Milan, Italy

Antonio Giachetti


Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 72(Granted Patents)


Location History:

  • Milano, IT (1987)
  • Mailand, IT (1987 - 1988)
  • Milan, IT (1985 - 1996)

Company Filing History:


Years Active: 1985-1996

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Antonio Giachetti: Innovator in Pharmacology

Introduction

Antonio Giachetti is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of pharmacology, particularly through his innovative work on benzimidazoline derivatives. With a total of 13 patents to his name, Giachetti has established himself as a key figure in the development of therapeutic compounds.

Latest Patents

Among his latest patents, Giachetti has developed benzimidazoline-2-oxo-1-carboxylic acid derivatives that are useful as 5-HT antagonists. One notable method involves treating a human host suffering from psychosis by administering a therapeutically effective amount of a specific compound. Additionally, he has created pharmacologically active benzimidazoline-2-oxo-1-carboxylic acid compounds aimed at treating anxiety in human hosts.

Career Highlights

Throughout his career, Giachetti has worked with notable companies such as Istituto De Angeli S.p.A. and Dr. Karl Thomae GmbH. His work in these organizations has allowed him to further his research and development in pharmacological innovations.

Collaborations

Giachetti has collaborated with esteemed colleagues, including Arturo Donetti and Enzo Cereda. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Antonio Giachetti's contributions to pharmacology through his innovative patents highlight his expertise and dedication to improving therapeutic methods. His work continues to influence the field and offers promising solutions for treating various psychological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…